The role of viral particle integrity in the serological assessment of foot-and-mouth disease virus vaccine-induced immunity in swine by Mansilla, Florencia Celeste et al.
RESEARCH ARTICLE
The role of viral particle integrity in the
serological assessment of foot-and-mouth
disease virus vaccine-induced immunity in
swine
Florencia Celeste Mansilla1☯, Cecilia Soledad Turco1☯, Marı´a Cruz Miraglia1, Fernando
Anı´bal Bessone2, Rau´l Franco2, Mariano Pe´rez-Filgueira1, Juan Manuel Sala3, Alejandra
Victoria CapozzoID1*
1 IVIT, Instituto de Virologı´a e Innovaciones Tecnolo´gicas, Consejo Nacional de Investigaciones Cientı´ficas y
Tecnolo´gicas (CONICET), Instituto Nacional de Tecnologı´a Agropecuaria (INTA), Hurlingham, Buenos Aires,
Argentina, 2 Estacio´n Experimental Agropecuaria “Marcos Jua´rez”, INTA, Marcos Juarez, Co´rdoba,
Argentina, 3 Estacio´n Experimental Agropecuaria “Mercedes”, INTA, Merdeces, Corrientes, Argentina
☯ These authors contributed equally to this work.
* capozzo.alejandra@inta.gob.ar
Abstract
The efficacy of foot-and-mouth disease virus (FMDV) inactivated vaccines is mainly depen-
dent on the integrity of the whole (146S) viral particles. If the intact capsids disassemble to
12S subunits, antibodies against internal-not protective epitopes, may be induced. Serologi-
cal correlates with protection may be hampered if antibodies against internal epitopes are
measured. Here we compared the performance of different ELISAs with the virus-neutraliza-
tion test (VNT) that measures antibodies against exposed epitopes. Sera from pigs immu-
nized with one dose of an expired commercial FMDV vaccine were used. This vaccine
contained about 50% of O1/Campos and over 90% of A24/Cruzeiro strains total antigen as
whole 146S particles. Specific-total antibodies were measured with the standard liquid-phase
blocking ELISA (LPBE). We also developed an indirect ELISA (IE) using sucrose gradient
purified 146S particles as capture antigen to titrate total antibodies, IgM, IgG1 and IgG2. A
good correlation was found between VNT titers and IgG-ELISAs for A24/Cruzeiro, with the
lowest correlation coefficient estimated for IgG2 titers. For O1/Campos, however, the pres-
ence of antibodies against epitopes different from those of the whole capsid, elicited by the
presence of 12S particles in the vaccine, hampered the correlation between LPBE and VNT,
which was improved by using purified O1/Campos 146S-particles for the liquid-phase of the
LPBE. Interestingly, 146S particles but not 12S were efficiently bound to the ELISA plates,
confirming the efficiency of the IE to detect antibodies against exposed epitopes. Our results
indicate that any serological test assessing total antibodies or IgG1 against epitopes exposed
in intact 146S-particles correlate with the levels of serum neutralizing antibodies in vaccinated
pigs, and might potentially replace the VNT, upon validation. We recommend that antigen
used for serological assays aimed to measure protective antibodies against FMDV should be
controlled to ensure the preservation of 146S viral particles.
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1. Introduction
Foot-and-mouth disease (FMD) is considered the most economically important disease that
affects cloven-hoofed animals such as pigs, cattle, sheep and goats [1]. It is caused by a picorna-
virus, the foot-and-mouth disease virus (FMDV), which comprises 7 serotypes and numerous
subtypes. FMD is enzootic in large regions of the world [2], especially in Asia, Africa and, to a
lesser extent, South America, where vaccination is used as a preventive method. Currently,
commercially available vaccines are based on chemically inactivated whole viral particles that
are formulated with aqueous or oil adjuvants [3].
Pigs are highly susceptible to oral infection with FMDV, presenting higher severity than
ruminants [4]. Pigs serve as airborne amplifiers of FMDV because one infected pig can excrete
up to 3,000 times more viral particles per day that a sheep or a cow [5]. Given the importance
of the pig in the transmission of foot-and-mouth disease and the current context of pig indus-
try growth worldwide, there is a strong need for simple and high-performance serological
techniques applicable to epidemiological monitoring and vaccine efficacy studies for this spe-
cie. Currently, the virus neutralization test (VNT) is applied. This assay is difficult to standard-
ize, cumbersome and inadequate to be used on a large scale. Moreover, it involves the
manipulation of live virus, which results in the risk of an outbreak. This point is particularly
relevant for FMDV-free regions, where live virus can only be manipulated under strict bio-
safety conditions. That is the reason why ELISAs are preferred, as they use inactivated virus,
are high-throughput and easily deployable to any laboratory [6].
Total antibodies are usually assessed by Liquid-Phase Blocking ELISA (LPBE), which
requires an inactivated virus suspension as well as capture and detector antibodies that are
usually prepared by immunizing rabbits and guinea pigs. These assays must be set-up for each
vaccine strain, consequently, they are useful for vaccine potency testing, but they are not con-
venient in the case of an outbreak with a non-related strain, since capture and detector anti-
bodies need to be produced and standardized. Measuring total IgG titers by ELISA does not
provide any information concerning the functionality of antibodies, and this is thought to be
the reason why a low correlation is found between LPBE titers and VNT or protection [6],
which may explain why the use of ELISAs is limited. There is a need for well-defined markers
for immunity induced by FMD vaccination. These markers could serve as surrogates of vac-
cine protective efficacy and would be helpful for the quick introduction of new or improved
vaccines in the future [5]
The infective virus particle has a sedimentation coefficient of 146S. It contains one molecule
of single stranded positive sense viral RNA and protein capsid comprising 60 copies of pro-
teins called VP1, VP2, VP3 and VP4, which is located internally. Under certain conditions,
146S particles can undergo an irreversible dissociation into stable pentamers (12S) that lack
VP4 [7–9]. Neutralizing antibody production is associated mainly with 146S particles [10] and
infectivity-related sites are exposed on the FMDV particle [11] whereas 12S particles stimulate
the production of low levels of neutralizing antibodies. Even when both the 146S and 12S par-
ticles contain the same proteins, the conformation of the polypeptides is different in the two
particles and the configuration required for the production of neutralizing antibody is largely
lost when the 146S particles are converted into 12S particles, as demonstrated before [17].
Moreover, vaccine efficacy relies on the presence of complete-intact viral particles [12,13],
mainly due to the capacity of this antigen to elicit antibodies against exposed epitopes, which
can conduct viral clearance in the case of infection.
Intact viral particles can be differentiated from pentamers by means of sucrose gradient
ultracentrifugation or size-exclusion chromatography [12–14]. Capsid integrity may be
affected by different vaccine excipients [15], thiomersal [16], mild temperatures and pH
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variations even if they occur for a short period, and particle stability is strongly dependent on
the viral strain [17,18]. For instance, A-strains´ capsids remain intact after an overnight incu-
bation at 37˚C while their O-strains counterparts do not [17]. Therefore, a long inactivation
step may disrupt O-strain capsids, and this fact has never been considered when using FMD
antigen for serology.
Even though the need of antibodies against exposed-neutralizing epitopes elicited by intact
capsids is well accepted as a correlate of protection by the FMD community [13,19], the role of
146S capsid stability in serology has never been assessed. In addition, vaccine-induced anti-
body response in terms of kinetics of neutralizing antibodies, total antibodies, and IgG sub-
types has not been deeply characterized in pigs. The aim of this work was to develop
serological techniques to assess the different aspects and kinetics of the antibody response
against FMDV in vaccinated pigs using purified viral particles that can be prepared from any
field virus. We hypothesized that the lack of concordance between VNTs and ELISA titers may
be due to the measurement of antibodies against internal “non-protective” epitopes that bind
to disrupted particles present in the antigen preparation used for ELISA. In this regard, the
involvement of antigen stability both in the vaccine and the ELISAs were considered and ana-
lyzed in terms of correlation with the neutralizing antibody titers.
2. Materials and methods
2.1 Animals
A group of 15 two-months-old piglets born to naïve dams, which had been recently weaned,
were used (mean weight: 10Kg, Canadian genetics). They were housed in a dedicated facility at
the Marcos Juarez Agricultural Experimental Station (INTA) located in Co´rdoba province,
Argentina. The sheds had enough space for 15 animals and ad-libitum water supply, feeder
and cleaning grid. Animal handling and sampling was carried out on this site, under the super-
vision of INTA´s veterinarians and following the guidelines of the local animal welfare com-
mittee. The national authority for animal health (SENASA) approved the procedures (permit
letter dated July 15th, 2015). Piglets were negative for antibodies against non-structural pro-
teins at the beginning of the experiments (tested with the Priocheck FMDV-NS kit, Thermo-
Fisher Scientific, MA, USA).
2.2 Vaccination and sampling
A commercial vaccine was used. The formulation applied in Argentina is a single-oil emulsion
containing four inactivated FMDV strains: O1/Campos/Brazil/58 (O1/Campos), A24 Cru-
zeiro/Brazil/55 (A24/Cruzeiro), A/Argentina/2001 (A/Arg/01) and C3/Indaial/Brazil/71 (C3/
Indaial) [20]. The vaccine was applied 22 months after the expiration date. The content of
146S and 12S particles was estimated from the areas under the curves after reading the sucrose
gradients (see below) with a serotype-specific antigen ELISA, as described before [17].
Twelve animals were immunized with 2 mL of vaccine by the intramuscular route in the
neck, following the producer´s specifications for pigs. Three animals were left unvaccinated as
sentinels. Serum samples were taken at 0, 10, 21- and 60-days post-vaccination (dpv).
2.3 Virus purification
FMDV A24/Cruzeiro and O1/Campos strains were kindly provided by Bioge´nesis-Bago´ S.A.
(Argentina) as inactivated and concentrated preparations from clarified-infected cell cultures.
Purified particles were obtained by a 15%-45% sucrose density gradient (SDG) centrifugation
method [21] further optimized in our laboratory [22]. Aliquots were kept at -80˚C. For
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estimating the percentage of 146S and 12S particles in the antigen phase, 10mL of the vaccines
was treated overnight with one volume of chloroform and the extracted aqueous fraction was
analyzed in a sucrose gradient. Collected fractions were analyzed by antigen ELISA following
standard methods [23].
2.4 Neutralization assay
Serum neutralizing antibodies were titrated by a conventional virus neutralization test (VNT)
using infective culture-adapted FMDV O1/Campos or A24/Cruzeiro strains (titer 107
TCID50/ml) on BHK-cell monolayers as described in the OIE Manual of Diagnostic Tests and
Vaccines for Terrestrial Animals [24] and adapted by Bucafusco et al [25]. The endpoint titers
of the serum samples were expressed as the logarithm (base 10) of the reciprocal of the last
dilution of serum that neutralized 100× TCID50 of the virus in 50% of the wells.
2.5 Liquid-phase blocking ELISA
Total anti-FMDV O1/Campos and A24/Cruzeiro antibodies were assessed by LPBE performed
as stated by the OIE Manual [24] using serotype-specific rabbit serum as capture antibody
[25]. Serum samples were incubated with a standardized dilution of a preparation of inacti-
vated virus preserved in glycerol and free (unbound) virus was detected with a strain-specific
guinea-pig antiserum. Alternatively, sucrose-gradient purified 146S particles were used as
ELISA antigen. Antibody titers were expressed as the reciprocal of the logarithm (base 10) of
the last dilution of serum giving the 50% of the absorbance recorded in the virus control wells
without serum [26].
2.6 Total antibody indirect ELISA
Assessment of specific IgG was performed as described by Lavoria et al. [27] with the following
modifications. Inactivated O1/Campos or A24/Cruzeiro 146S purified particles were used as
capture antigen in carbonate-bicarbonate buffer (pH = 9.6), by incubating overnight at 4˚C.
After blocking for 90 minutes (PBS/ 10% Equine serum), different serum dilutions (from 1: 25
to 1: 12,800) were tested and the presence of anti-FMDV antibodies was revealed with a perox-
idase-conjugated goat anti-swine IgG diluted 1:3000 (BioRad, CA, USA) followed by ABTS/
H2O2. Titers were estimated as the reciprocal of the dilution giving an OD value above the cut-
off, estimated as the average OD value of pre-immune sera diluted 1:25 + 2 SD.
We estimated the intra-plate and intra-day repeatability of this indirect ELISAs. The intra-
laboratory repeatability (intermediate precision) was estimated with results obtained by two
different technicians, using 3 replicates of ten samples with high VNT titers against O1/Cam-
pos strain (VNT titer>1.7). Samples were run in three different days, using three different
reagent batches. Coefficients of variation for positive control samples were below 10% for all
the operators for each assay. No significant differences were found between mean OD values
determined by two different laboratories (p>0.05). ANOVA analysis showed there were no
differences in the OD values due to the operator or their repeatability (p values were 0.55 and
0.68 respectively), meaning that the assays can be performed on different days and by different
operators without modifying the results.
2.7 Isotype ELISAs
The procedure and set-up for IgM, IgG1 and IgG2 ELISAs were the same as described for total
IgG except that different conjugates were used. Mouse anti-swine IgG1 (MCA635GA, clone
K139 3C8, 1:7500), IgG2 (MCA636GA, clone K68 Ig2, 1:10000) and IgM (MCA637GA, clone
PLOS ONE FMDV particle integrity and serology
PLOS ONE | https://doi.org/10.1371/journal.pone.0232782 May 5, 2020 4 / 13
K52 1C3 1:10000) were used (all from BioRad), followed by a goat anti-mouse IgG peroxidase
conjugated (1:1000, KPL, MD, USA), adapted from Capozzo et al 1997 [28] and Lavoria et al.
2012 [27].
2.8 Binding capacity of 146S vs 12S articles to ELISA plates
A preparation containing 1,300 μg/mL of whole viral purified particles of O1/Campos, pre-
served in aliquots at -80˚C, was either used directly to coat plates with PBS or carbonate/Bicar-
bonate buffer (pH: 9.6) or treated at 60˚C for 20 minutes to produce 12S particles, as described
before [17]. Different ratio of 146S to 12S particles were prepared and used to coat duplicate
wells. The absence of 146S particles in the heated preparations was confirmed by sucrose-gra-
dient ultracentrifugation. Purified IgG at the same concentration was used as control. ELISA
plates were incubated overnight at 4˚C, following the standard procedure. The next day, plates
were washed five times with PBS-Tween 20 (0.05%) and bound total proteins were quantified
using Micro BCA kit (Thermo Fisher) following the manufacturer´s instructions.
The same design was used to run 10 serum samples from 60 dpv vaccinated animals
(diluted 1: 50) comparing the OD values for each captured antigen preparation with that of the
whole particles (expressed as percentage of residual reactivity)
2.9 Statistical analysis
Area under the curve was estimated using the trapezoid rule. Serological assays were per-
formed blinded to the results of the other tests and were then compared all together and to
their VNT titers. VNT titers were used to build scatter plots showing the relationship between
values produced by the different ELISAs and VNT titers. To determine the level of agreement
between results obtained by the different ELISAs and VNT we computed Pearson´s correla-
tion and linear regression analysis. Pairwise comparisons were assessed by the Mann-Whitney
test, and results from multiple treatments were compared by means of the Krustall-Wallis test,
followed by the Dunn´s multiple-comparisons test. In all instances, a confidence interval of
95% was considered. The analyses were performed with GraphPad Prism v5.0 (GraphPad Soft-
ware, CA, USA).
3. Results
3.1 Kinetics of Ig-subtype responses in vaccinated pigs
An expired commercial vaccine was used and the relative content of whole and disrupted par-
ticles was estimated by sucrose gradient ultracentrifugation. Two peaks were identified by
reading the collected gradient fractions in a strain-specific antigen ELISA (Fig 1), correspond-
ing to 146S (peak 1) and 12S particles (peak 2). Relative content of both antigenic species was
estimated by computing the area under the curve (Fig 1). The applied vaccine had approxi-
mately 93% of intact 146S A24/Cruzeiro particles and ~50% of the total amount antigen were
whole O1/Campos particles (Table 1).
A group of 12 piglets was immunized with this vaccine, and three animals were left unvacci-
nated. Serum samples collected at 0, 10, 21 and 60 dpv were assessed for neutralizing, total
antibodies, IgM, IgG1 and IgG2 titers. Vaccinated pigs elicited IgM against both strains shortly
after vaccination, high levels were detected at 10 dpv. At that time point, IgG was undetectable
in most of the animals. IgM levels decayed by 21 dpv and the IgG switch occurred with a con-
comitant increase of both IgG1 and IgG2 titers (Fig 2A). Kinetics of IgG1 and IgG2 responses
were different for both strains (Fig 2B). While IgG2 levels increased for both strains between
21 and 60 dpv, IgG1 titers remained within the same levels at both time points for O1/Campos
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and increased significantly for A24/Cruzeiro (Fig 2B). At 60 dpv, IgG2 titers were higher than
IgG1 against O1/Campos (p<0.05; Fig 2C) for O1/Campos. Both IgG1 and IgG2 titers were
higher for A24/Cruzeiro than for O1/Campos at 60 dpv (Fig 2C).
Fig 1. Antigen content in the expired FMDV vaccine. The aqueous phase was extracted with one volume of
chloroform and run in a sucrose gradient. Fractions were recovered, read by OD = 260 and then antigen peaks were
identified with a strain-specific antigen ELISA. Peaks for 146S and 12S particles are indicated.
https://doi.org/10.1371/journal.pone.0232782.g001
Table 1. Analysis of the area under the curve. Data from Fig 1.
A24 Cruzeiro O1 Campos
Baseline 0,300 0,300
Total Area 7,473 5,599
Total Peak Area 6,959 4,695
Number of Peaks 2,000 2,000
Peak 1 (146 S)
First X = 9,000 9,000
Last X = 17,80 15,00
Peak X = 11,00 11,00
Peak Y = 2,346 1,300
Peak Y—Baseline = 2,046 1,000
Area = 6,469 2,415
% Area = 92,95 51,44
Peak 2 (12S)
First X = 28,32 28,00
Last X = 33,57 34,00
Peak X = 30,00 30,00
Peak Y = 0,6040 1,400
Peak Y—Baseline = 0,3040 1,100
Area = 0,4906 2,280
% Area = 7,050 48,56
https://doi.org/10.1371/journal.pone.0232782.t001
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3.2 Total and neutralizing antibodies induced after vaccination
Serum samples were assessed for neutralizing and total antibodies using the VNT and two dif-
ferent ELISA assays, LBPE and IE. Total antibodies were detected as soon as 10 dpv when
using IE while only some animals were positive by LPBE. Antibody titers increased signifi-
cantly from 10 to 21 dpv (p<0.05) for both virus strains and had similar levels until the end of
the experiment (Fig 3A). Neutralizing antibody titers against A24/Cruzeiro were above the
detection levels for some animals at 10 dpv while none of the animals elicited detectable neu-
tralizing antibodies against O1/Campos at this time point (Fig 3A). VNT titers increased for
Fig 2. Isotype responses. (A) Kinetics of IgM, IgG1 and IgG2 in vaccinated pigs, mean titers ± SD are depicted. (B)
Comparison of mean IgG1 and IgG2 titers at 21 and 60 dpv against both A24/Cruzeiro and O1/Campos strains. (C)
Pairwise comparative analysis of IgG1 and IgG2 levels measured at 60 dpv.
https://doi.org/10.1371/journal.pone.0232782.g002
Fig 3. Total and neutralizing antibodies. (A) Kinetics of neutralizing antibodies (VNT) and total antibody titers
measured with liquid-phase blocking ELISA (LPBE) or indirect ELISA (IE) as indicated. Mean titers ± SD are depicted.
(B) Comparison of LPBE, IE and VNT titers at 60 dpv against A24/Cruzeiro and O1/Campos strains. (C) Pairwise
comparative analysis of neutralizing and total antibody levels (estimated using LPBE) at 21 vs 60 dpv, for both strains.
Statistically significant differences between groups are indicated.
https://doi.org/10.1371/journal.pone.0232782.g003
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both viruses at 21 dpv (Fig 3A) with mean values significantly higher than pre-immune titers
(p<0.05).
At 60 dpv, total antibodies measured by LPBE were similar between both strains, while IE
and VNT showed differences, with significantly lower titers for O1 Campos compared to A24/
Cruzerio strain (p<0.05; Fig 3B).
We then compare the raise in total and neutralizing antibody titers between 21 and 60 dpv.
VNT titers were similar between 21 and 60 dpv for A24/Cruzeiro but significantly different for
O1/Campos strain (p<0.05; Fig 3C). The same trend was found for IE titers while LPBE levels
remained invariable between both time points (Fig 3D).
3.3 Correlation between ELISA and VNT titers
Correlation analyzes were performed between neutralizing antibody titers and both IgG-sub-
type and total antibody levels measured by ELISA (Fig 4). Correlations were significant for all
the ELISAs when measuring antibodies against A24/Cruzeiro, with the highest correlation
coefficient for IgG1 (r2 = 0.86), followed by LPBE and VNT (r2 = 0.77), being the lowest (r2 =
0.71) for IgG2 titers (Fig 4A). Correlation analysis for O1/Campos titers yielded different
results. While there was a good correlation between both IgG1 and IE titers (Fig 4B) and VNT
(r2 = 0.74), coefficients were much lower for LPBE and IgG2 levels (r2 = 0.47 and r2 = 0.63,
respectively).
3.4 Relevance of whole particles in FMDV serological assessments
Antibody levels induced against each one of the FMDV strains included in current commercial
vaccines are always similar and comparable. However, as it was shown previously, the ratio
between whole and disrupted particles in the expired vaccine was different for the O1/Campos
and A24/Cruzeiro strains. As there was an evident effect of the relevance of measuring anti-
bodies against whole capsids by IE and the correlation of these antibodies against exposed epi-
topes and VNT titers, we designed an experiment to assess if the increased amounts of 12S
pentamers bound to the ELISA plate could modify the correlation with VNT. ELISA plates
were coated with different ratios of 146S to 12S particles from the O1/Campos and A24/Cru-
zeiro strains, tested with a single dilution (1:50) of 60 dpv serum samples, and results were
compared to those estimated by using only purified146S particles (Fig 5).
Serum reactivity against the coating antigen diminished when increasing the amount of 12S
particles in the coating mixture, this was a consistent result yielded by each tested sample. This
means that either antibodies against capsid-internal epitopes exposed in 12S particles are
absent or that 12S particles were not efficiently bound to the plate. To test this later hypothesis,
we coated plates with an excess amount of either 146S or 12S particles and then quantified
total protein effectively bound to the plate. Two different coating buffers were tested in order
to see if there was a role of the buffer in the binding capacity of the viral particles to the ELISA
plate. Results are shown in Table 2. While 146S particles reached the maximum binding capac-
ity of the wells, 12S particles bound less efficiently. Moreover, the use of carbonate/bicarbonate
buffer precluded the binding of 12S pentamers, and only 20% of total protein was retained
onto the ELISA plate, meaning that the IE coating conditions will favor the binding of whole
viral particles.
As a whole, these results would indicate that good correlation with VNT titers required the
measurement of antibodies against exposed epitopes present in whole viral particle. If this is
correct, then the correlation between LPBE and VNT titers should be improved if performing
the assay (specifically the incubation of the virus with serum antibodies in a liquid phase) in
the absence of 12S particles. To test this hypothesis, we designed an experiment using freshly
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purified 146S O1/Campos particles for the liquid phase, incubating at 4˚C for two hours
(instead of 1h at 37˚C) to ensure the preservation of the whole viral particles. We verified that
performing LPBE with 146S particles improved the correlation with VNT, modifying the cor-
relation coefficient from 0.47 with the regular un-controlled antigen to 0.72 when using exclu-
sively intact viral particles (Fig 6).
4. Discussion
The aim of this work was to assess humoral responses in FMDV vaccinated pigs, considering
different aspects of the antibody response apart from neutralizing antibodies, such as total
antibodies and isotypes induced. For this purpose, we developed indirect ELISA assays adapt-
ing those already used for bovine sera in our laboratory [27].
A well-known fact among FMDV laboratories is that titers estimated by the currently used
ELISAs do not always correlate with those measured by the VNT. Others and we have pro-
posed that the lack of correlation is a consequence of not measuring the correct protection
marker [6,29]. Here we demonstrated that, besides that, a simple technical issue like using dis-
assembled viral particles may account, at least partially, to the low correlation sometimes
observed; and that this phenomenon can be especially important for certain labile strains.
It is well known and demonstrated by our group and others, that type-O are less stable than
A strains [17]. In addition, different authors have demonstrated that disrupted viral particles
Fig 4. Correlation between virus neutralizing and ELISA titers. (A) Correlation between neutralizing antibody titers
(VNT titer) and IgG1 (upper panel) or IgG1 (lower panel) for both A24/Cruzeiro and O1/Campos strains. (B)
Correlation analysis between VNT titers and total antibody levels estimated by LPBE (upper panels) or IE (lower
panels). Linear correlation coefficients (r2) and Pearson´s r values are shown in each graph. Red values indicate a poor
correlation between VNT and IgG2 or LPBE titers for O1/Campos strain.
https://doi.org/10.1371/journal.pone.0232782.g004
Fig 5. Impact of binding 12S particles in indirect ELISA. ELISA plates were coated with different amounts of 146 S
and 12S particles of O1/Campos (A) or A24/Cruzeiro (B), mixed together at the indicated rates. Serum samples from
vaccinated pigs were measured in single dilution (1:50) and OD values were compared to those obtained for whole
146S particles and expressed as percentage of reactivity.
https://doi.org/10.1371/journal.pone.0232782.g005
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(12S pentamers) are less immunogenic and elicit a diminished neutralizing response [13,19].
Moreover, 12S particles may expose internal epitopes to B-cells, and antibodies against non-
protective epitopes can be elicited. In order to analyze the immune response in these condi-
tions we used an expired vaccine that contained only half the amount of the total O1 Campos-
antigen as 146S particles. In contrast, due to the intrinsic stability features of A and O strains,
most of the whole A24/Cruzeiro particles were preserved.
Isotype responses as well as total antibody titers against commercial FMD vaccines have
not been deeply characterized in pigs. A typical primary immune response was observed, char-
acterized by a peak of IgM at 14 dpv that decreased at 21 dpv, as previously shown by Oul-
dridge et al and Cox [30,31] et al. IgG responses were detected in some animals at 14 dpv and
in all of them at 21 dpv. Cox et al showed that IgG switch can occur from 9 dpv [31], with an
IgG1 peak around 28 days, followed later by IgG2. Here we found that both IgG1 and IgG2
increased significantly between 21 and 60 dpv for both strains. At 60 dpv, IgG1 and IgG2 titers
against A24/Cruzeiro were similar, while significant differences between these isotypes were
observed at 60 dpv for O1/Campos. It is important to consider differences related to the assay
itself, as Cox et al. used a sandwich ELISA with a capture hyper-immune serum that can poten-
tially bind both whole and disrupted particles. We speculate this difference may be related to
the presence of antibodies against internal, protection-irrelevant epitopes. In this regard, it is
worth noting that IgG2 titers correlate poorly with VNT titers.
Several studies described the kinetics of FMDV-neutralizing responses using commercial
vaccines [32]. VNT titers have been associated with protection in pigs. A study described high
levels of protection with VNT titers over 1.7 in pigs against an O strain and claimed that anti-
body titers between 1 and 1.6 are in a so-called “grey zone” where protection cannot be dis-
cerned [33]. In our study, the vaccine induced antibody levels over 1.6 at 21 dpv. These peak
levels were maintained at 60 dpv for A24/Cruzeiro, but not for O1/Campos. The high content
of 12S particles in O1/Campos vaccine might not favor the adequate development of T-cell
immunity, known to require whole 146S-particles to be tackled [17]. In this regard, it is impor-
tant to consider the differences in the immunogenicity among virus strains (i.e. due to their
intrinsic particle stability) that can also impact in the antibody repertoire and avidity
maturation.
Indirect ELISAs use sucrose-gradient purified 146S particles as coating material, and sam-
ples are incubated directly onto this solid-phase, while LPBE involves an incubation step of the
sample with an inactivated virus-culture suspension. Protocols for BEI inactivation of the
infectious FMDV supernatants in the serology laboratories are usually the same for any strain,
with a fixed amount of BEI concentration, time and temperature. These conditions may be
harsh from some strains and compromise the stability of the whole capsids, affecting the final
readout of the diagnostics. This is an important issue when evaluating vaccine efficacy using
serology as antibodies against non-exposed epitopes, elicited by 12S particles included in the
vaccines, may be detected but are irrelevant for protection.
Table 2. Binding of 146S and 12S particles onto the ELISA plates. Excess amount of antigen was coated ON using
either PBS or Carbonate/bicarbonate buffer. Plates were washed after the ON incubation at 4˚C and total coated pro-
teins were quantified using a commercial kit.
Antigen PBS Carb/Bicarb
146S 14.48 13.77
12S 6.36 3.07
Purified IgG 14.59 15.01
https://doi.org/10.1371/journal.pone.0232782.t002
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The virus neutralization test is by itself a selective assay that only measure antibodies against
exposed epitopes. The use of intact viral particles to coat plates together with the fact that 12S
pentamers are not bound to the plate, position indirect ELISAs as a more reliable option than
blocking or liquid phase ELISAs for measuring protective antibodies. An additional advantage
of IE is avoiding the need of using a capture or detector antibody, which may not be timely
available for an emerging field strain.
Finally, a hear-and-say issue around binding purified particles directly to the ELISA plates
is the possibility of losing structure once the virus is coated. The good correlation observed
with VNT titers by all the assays based on purified virus, irrespectively of what they measure,
together with the fact that this good correlation is achieved even when using serum samples
with antibodies against internal epitopes, are strong evidences of the conservation of the parti-
cle structure once bound to the ELISA plates.
We believe that an important contribution of this study is the set-up and evaluation of an
indirect ELISA based on purified-146S particles as coating antigen for titrating total antibodies
in swine sera. This assay gives a better correlation with VNT and avoids the need of developing
capture and detector antibodies. The use of this ELISA should be considered as an alternative
to the VNT provided a fit-for-purpose validation is conducted, probably also reducing cross-
reactivity between strains. In conclusion, we strongly recommend that virus used for serologi-
cal assays should be controlled for capsid integrity to ensure the detection of antibodies against
exposed (protection-relevant) epitopes.
Supporting information
S1 Fig. Control of particle stability before performing ELISA (example for O1/Campos,
experiment shown in Fig 6). The dotted square indicates the fractions used in ELISA.
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